Likewise, the remaining serious pathology in the animals treated with L-NAME + L-arginine indicates that other system(s) ( i.e ., the BPC 157 system) may function along with the NO system, which was previously supposed to be inactivated by the combined action of L-NAME and L-arginine[3,52,53]
In clinical use, the most commonly reported side effects are: Mild injection site redness or swelling (resolves within hours) Occasional lightheadedness following injection (less common, position-dependent) Temporary nausea with oral administration in some patients Who should not use BPC-157: Patients with active cancer or a history of cancer should discuss BPC-157 carefully with their oncologist before use angiogenic peptides theoretically could support tumor vascularity, though no evidence of this has been demonstrated in animals
Notably, BACH1 is traditionally recognized as an angiogenesis inhibitor that regulates HO-1 or VEGF transcription
Where to inject
Once reconstituted, the solution requires refrigeration and maintains potency for approximately 2 to 4 weeks with proper handling
